TPVG logo

TRIPLEPOINT VENTURE GROWTH B

TPVGNYSE
πŸ† #3651 by market capEarnings Nov 4 Β· PostUS Equity
$4.55β–² $0.06 (+1.45%)
Market closed Β· at close
πŸ””
Track TPVG
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 1.4%
7dβ–² 5.9%
14dβ–² 2.6%
30dβ–Ό 6.5%
ytdβ–Ό 30.3%
1yβ–Ό 16.5%
🏦Market Cap
$185M
Small Cap
πŸ“ˆRevenue Growth (YoY)
12.6%
Healthy
πŸ“ŠGross Margin
52.3%
Healthy
πŸ’΅FCF Margin
44.3%
Strong
βš–οΈP/S Ratio
1.7x
Cheap
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
$4.48 – $4.55
52-Week Range
$4.15 – $6.95
Volume (shares)
11,641
Avg Volume (shares)
β€”
Shares Outstanding
40.7M
Next Earnings
2026-11-04

Fundamentals Snapshot

Annual Revenue
$97M
Last Q Revenue
$24M
P/E Ratio
4.5
P/S Ratio
1.7x
EPS (TTM)
$0.99
Dividend Yield
19.84%
Dilution (1yr)
+0.9%
TPVG logo

TRIPLEPOINT VENTURE GROWTH B

TPVG
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$97Mβ–² +36.6% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
83.5%β–² +30.6% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$76Mβ–² +136.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$57Mβ–Ό βˆ’137.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
40.4Mβ–² +0.9% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$449Mβ–Ό βˆ’$96M YoY
StockOtter Β· stockotter.space

About TRIPLEPOINT VENTURE GROWTH B

TriplePoint Venture Growth BDC Corp. (TPVG) functions as a business development company, primarily concentrating its investments on growth-stage enterprises backed by venture capital. The firm's core offering involves providing debt financing solutions to companies within the venture growth ecosystem. These solutions encompass a diverse range of products, such as growth capital loans, customized and secured credit facilities, equipment financing, and revolving lines of credit. Additionally, TPVG engages in direct equity investments. Its investment strategy targets companies operating in key sectors, including e-commerce, entertainment, technology, and life sciences. Within the technology sphere, the areas of specific interest are broad, covering cybersecurity, wireless communication equipment, network systems and software, business application software, conferencing solutions, big data analytics, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, various software categories (including Software-as-a-Service), and other related technological subsectors. For life sciences, TPVG focuses on biotechnology, biofuels/biomass, diagnostic testing and bioinformatics, drug delivery systems, drug discovery, healthcare information systems, healthcare services, medical/surgical/therapeutic devices, pharmaceuticals, and other related fields. The size of TPVG's investments varies based on the type of financing: growth capital loans typically range from $5 million to $50 million, equipment financings are between $5 million and $25 million, and revolving loans generally fall between $1 million and $25 million. Direct equity investments, conversely, are usually from $0.1 million to $5 million, and are structured to not exceed 5% of the portfolio company's total equity. The debt financing instruments are commonly structured as lines of credit, and the company also employs warrants and secured loans in its funding approach. TPVG aims to achieve targeted returns of 10% to 18%. A distinctive aspect of its investment policy is that it does not seek board representation in the companies it finances.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100

Analyst Ratings

β“˜
Consensus
Sell
9 analysts
Strong Buy0
Buy0
Hold6
Sell1
Strong Sell2
Ratings as of Oct 2026

Latest News & Updates

News unavailable.